MBX Biosciences reported cash from operations of -$22.62M and free cash flow of -$23.52M for the quarter ended Jun 2026, down 29.8% year over year. This cash flow statement covers 12 quarters of results from Sep 2023 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Cash Flow Statement | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||
| Net Income | -10.16M | -8.84M | -12.34M | -15.86M | -18.14M | -15.59M | -23.88M | -19.41M | -21.62M | -22.06M | -23.52M | -37.09M |
| Share-based Compensation | 0.60M | 1.02M | 1.62M | 0.92M | 18.20M | 1.49M | 4.30M | 22.10M | 22.30M | 2.66M | 40.70M | 47.00M |
| Cash from Operations | -11.15M | -10.71M | -13.27M | -14.66M | -16.04M | -22.68M | -17.43M | -21.54M | -18.30M | -20.21M | -22.62M | |
| Depreciation, Depletion & Amortization | ||||||||||||
| Amortizatization of Intangibles | 0.60M | 0.50M | 0.44M | 0.59M | 1.40M | 1.34M | 0.98M | 0.73M | 0.56M | 0.58M | 0.42M | |
| Change in Working Capital | ||||||||||||
| Change in Account Payables | -0.31M | 0.47M | 0.58M | 2.23M | 0.65M | -1.56M | 2.01M | -2.04M | -0.86M | 3.97M | -3.23M | |
| Change in Accured Expenses | -1.18M | -0.41M | 2.64M | 1.15M | -0.20M | 0.56M | -0.25M | 2.04M | 4.45M | -4.86M | 11.20M | |
| Other Working Capital Changes | 1.32M | -0.41M | 1.16M | 0.57M | 1.03M | -1.65M | 0.80M | 1.54M | 2.00M | 0.72M | 2.02M | |
| Investing Activities | ||||||||||||
| Capital Expenditures | 0.06M | 0.27M | 0.45M | 0.06M | 0.09M | 0.50M | 0.23M | 0.40M | 0.79M | 0.44M | 0.90M | |
| Change in Acquisitions & Divestments | 5.00M | 24.25M | 8.25M | 27.00M | 20.25M | 57.15M | 73.12M | 61.35M | 76.25M | 57.50M | 84.00M | |
| Cash from Investing Activities | -28.95M | 15.43M | -7.89M | -100.79M | -67.34M | 3.23M | 25.99M | 17.06M | -129.97M | -97.10M | 29.21M | |
| Financing Activities | ||||||||||||
| Other financing activities | 0.02M | 0.19M | 0.05M | 174.30M | 0.00M | 1.33M | 0.13M | 0.95M | 2.44M | 2.19M | ||
| Change in Capital Stock | ||||||||||||
| Net Shares Issued and Repurchased | 1.75M | 1.39M | 0.91M | 1.76M | 0.72M | |||||||
| Misc. | ||||||||||||
| Cash from Financing Activities | 0.02M | 0.18M | -1.76M | 235.81M | -0.13M | 0.00M | 1.33M | 187.82M | 0.44M | 87.44M | 2.32M | |
| Change in Cash | -40.08M | 4.90M | -22.92M | 120.36M | -83.51M | -19.45M | 9.88M | 183.34M | -147.84M | -29.87M | 8.91M | |
| Free Cash Flow | -11.20M | -10.98M | -13.72M | -14.72M | -16.13M | -23.18M | -17.67M | -21.93M | -19.09M | -20.64M | -23.52M | |
| Net Cash Flow | -40.08M | 4.90M | -22.92M | 120.36M | -83.51M | -19.45M | 9.88M | 183.34M | -147.84M | -29.87M | 8.91M |